C-KIT EXPRESSION DOES NOT PREDICT RESPONSE TO IMATINIB MESYLATE AS SECOND-LINE THERAPY IN PATIENT WITH METASTATIC SOFT TISSUE LEIOMYOSARCOMA


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles